Page 15 - Jon Davis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tests for sick newborns that look at their full genetic blueprints are nearly twice as good at finding genetic problems as narrower, more commonly used tests, a recent study found. According to the research, published in the Journal of the American Medical Association, the broader tests found 49% of genetic abnormalities, compared with 27% for the narrower tests. Experts say this offers hope to parents of millions of babies with confounding conditions.

Brynn Schulte nearly died twice when she was a baby, at one point needing emergency surgery for massive bleeding in her brain. No one knew what was wrong until a test that looked at her full genetic blueprint found a rare bleeding disorder called factor XIII deficiency.

Tests for sick newborns that look at their full genetic blueprints are nearly twice as good at finding genetic problems as narrower, more commonly used tests, a recent study found. According to the research, published in the Journal of the American Medical Association, the broader tests found 49% of genetic abnormalities, compared with 27% for the narrower tests. Experts say this offers hope to parents of millions of babies with confounding conditions.

Tests for sick newborns that look at their full genetic blueprints are nearly twice as good at finding genetic problems as narrower, more commonly used tests, a recent study found. According to the research, published in the Journal of the American Medical Association, the broader tests found 49% of genetic abnormalities, compared with 27% for the narrower tests. Experts say this offers hope to parents of millions of babies with confounding conditions.

Tests for sick newborns that look at their full genetic blueprints are nearly twice as good at finding genetic problems as narrower, more commonly used tests, a recent study found. According to the research, published in the Journal of the American Medical Association, the broader tests found 49% of genetic abnormalities, compared with 27% for the narrower tests. Experts say this offers hope to parents of millions of babies with confounding conditions.